Host: |
HEK293 cells |
Reactivity: |
Human |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Recombinant-Human Transthyretin/TTR-C-His protein was developed from hek293 cells and has a target region of C-His. For use in research applications. |
Formulation: |
Lyophilized from a 0.22 Mu m filtered solution of PBS, pH 7.4. Contact us for customized product form or formulation. |
Gene Symbol: |
TTR |
Gene ID: |
7276 |
Uniprot ID: |
TTHY_HUMAN |
Immunogen: |
Recombinant Human Transthyretin/TTR Protein is produced by HEK293 expression system. The target protein is expressed with sequence (Gly 21-Glu 147 ) of human Transthyretin (Accession #NP_000362.1) fused with a 6Ă—His tag at the C-terminus. |
Tissue Specificity | Detected in serum and cerebrospinal fluid (at protein level). Highly expressed in choroid plexus epithelial cells. Detected in retina pigment epithelium and liver. |
Post Translational Modifications | Not glycosylated under normal conditions. Following unfolding, caused for example by variant AMYL-TTR 'Gly-38', the cryptic Asn-118 site is exposed and glycosylated by STT3B-containing OST complex, leading to its degradation by the ER-associated degradation (ERAD) pathway. Sulfonation of the reactive cysteine Cys-30 enhances the stability of the native conformation of TTR, avoiding misassembly of the protein leading to amyloid formation. |
Function | Thyroid hormone-binding protein. Probably transports thyroxine from the bloodstream to the brain. |
Protein Name | TransthyretinAttrPrealbuminTbpa |
Database Links | Reactome: R-HSA-2453864Reactome: R-HSA-2453902Reactome: R-HSA-3000171Reactome: R-HSA-6798695Reactome: R-HSA-975634Reactome: R-HSA-977225 |
Cellular Localisation | SecretedCytoplasm |
Alternative Protein Names | Transthyretin proteinAttr proteinPrealbumin proteinTbpa proteinTTR proteinPALB protein |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance